Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.02 (+9.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

Theriva Biologics (TOVX) Asset Utilization Ratio (2011 - 2026)

Updated

Theriva Biologics' (TOVX) Asset Utilization Ratio stood at -0.01 in Q2 2026.

Analysis

Theriva Biologics (TOVX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Starting with Q3 2011, Theriva Biologics' Asset Utilization Ratio history includes 4 quarters.

  • The Q2 2026 figure is the lowest quarterly Asset Utilization Ratio since Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.49
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.47
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.52
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.44
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.53
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.58
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 0.47
10 Theriva Biologics 10.56 Mn 10.56 Mn - -0.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.01
Mar 31, 2026 0.00
Dec 31, 2011 -0.03
Sep 30, 2011 0.11
API Access

Theriva Biologics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TOVX&period=max&api_key=YOUR_API_KEY